San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Ascus Biosciences is raising $5,000,000.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Michael Seely played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Ascus Biosciences

The mission at Ascus Biosciences is better microbes for a better life. Based in San Diego, CA, Ascus is focused on discovering, developing, and commercializing first-in-class endomicrobial products for the animal health and nutrition industries. Founded in 2015, Ascus is pioneering the emerging science of endomicrobial ecology to illuminate microbial communities within animals, and the role they play in overall health and performance. Ascus has a broad pipeline of all-natural, endomicrobial products in development across livestock and companion animals.

To learn more about Ascus Biosciences, visit http://ascusbiosciences.com/

Contact:
Michael Seely, President and Chief Executive Officer
877-696-8945
https://www.linkedin.com/in/michaelseely/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved